Discussion of “Power Priors for Leveraging Historical Data: Looking Back and Looking Forward”✩
Volume 23, Issue 1 (2025), pp. 56–58
Pub. online: 4 February 2025
Type: Discussion
Open Access
Open Access
✩
Main article: https://doi.org/10.6339/24-JDS1161.
Published
4 February 2025
4 February 2025
References
Blei DM, Kucukelbir A, McAuliffe JD (2017). Variational inference: A review for statisticians. Journal of the American Statistical Association, 112(518): 859–877. https://doi.org/10.1080/01621459.2017.1285773
Carvalho LM, Ibrahim JG (2021). On the normalized power prior. Statistics in Medicine, 40(24): 5251–5275. https://doi.org/10.1002/sim.9124
Chen MH, Guan Z, Lin M, Sun M (2025). Power priors for leveraging historical data: Looking back and looking forward. Journal of Data Science, 23(1): 1–30. https://doi.org/10.6339/24-JDS1161.
Gravestock I, Held L (CN Consortium) (2017). Adaptive power priors with empirical Bayes for clinical trials. Pharmaceutical Statistics, 16(5): 349–360. https://doi.org/10.1002/pst.1814
Han Z, Zhang Q, Wang M, Ye K, Chen MH (2023). On efficient posterior inference in normalized power prior Bayesian analysis. Biometrical Journal, 65(5): 2200194. https://doi.org/10.1002/bimj.202200194
Ibrahim JG, Chen MH (2000). Power prior distributions for regression models. Statistical Science, 15(1): 46–60. https://doi.org/10.1214/ss/1009212673
Ormerod JT, Wand MP (2010). Explaining variational approximations. American Statistician, 64(2): 140–153. https://doi.org/10.1198/tast.2010.09058
Pawel S, Aust F, Held L, Wagenmakers EJ (2023). Normalized power priors always discount historical data. Stat, 12(1): e591. https://doi.org/10.1002/sta4.591
Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, et al. (2014). Use of historical control data for assessing treatment effects in clinical trials. Pharmaceutical Statistics, 13(1): 41–54. https://doi.org/10.1002/pst.1589
